Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 25/09/17

Trade details

Type
Insider sale
Amount
$1,201,770
Shares · price
3,000 sh · $400.59 a share
Held after
130 sh
Trade date
25/09/16
Filed
25/09/17
Days to filing
1 days

Sold 95.8% of holdings

Share of holding sold
95.8%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/17~25/10/16

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1.1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $664.2K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $574.9K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $262.3K

    Filed 09/30

Martine A. Rothblatt, Chairman — sold $1.2M of United Therapeutics UTHR · 95.8% of holdings · 10b5-1 plan | Whalegun